Atopic dermatitis induces the expansion of thymus-derived regulatory T cells exhibiting a Th2-like phenotype in mice

Journal of Cellular and Molecular Medicine

Volumn 20, Issue 5, 2016, Pages 930-938

  Moosbrugger Martinz, Verena ^a   Tripp, Christoph H ^a   Clausen, Björn E ^b   Schmuth, Matthias ^a   Dubrac, Sandrine ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Atopic dermatitis; Regulatory T cells; Thymic stromal lymphopoietin; Vitamin D3

Indexed keywords

CALCIPOTRIOL; CD103 ANTIGEN; CD4 ANTIGEN; COLECALCIFEROL; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLYCOPROTEIN A REPETITION PREDOMINANT RECEPTOR; IMMUNOGLOBULIN E; INDUCIBLE T CELL COSTIMULATOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; CYTOKINE; ICOS PROTEIN, MOUSE; LRRC32 PROTEIN, MOUSE; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATOPIC DERMATITIS; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL EXPANSION; CELL VIABILITY; CONTROLLED STUDY; DENDRITIC CELL; EPIFLUORESCENCE MICROSCOPY; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; LYMPH NODE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; TH2 CELL; ANIMAL; C57BL MOUSE; CELL PROLIFERATION; CYTOTOXIC T LYMPHOCYTE; DERMATITIS, ATOPIC; DISEASE MODEL; DRUG EFFECTS; EPIDERMIS; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; PATHOLOGY; SIGNAL TRANSDUCTION; TH1 TH2 BALANCE; THYMUS;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHOLECALCIFEROL; CTLA-4 ANTIGEN; CYTOKINES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; EPIDERMIS; GENE EXPRESSION REGULATION; HUMANS; INDUCIBLE T-CELL CO-STIMULATOR PROTEIN; LANGERHANS CELLS; LYMPH NODES; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; TH1-TH2 BALANCE; THYMUS GLAND;

EID: 84959535213     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12806     Document Type: Article

References (45)

1. Elias PM, Schmuth M. Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol. 2009; 9: 437-46.
2. Leung DY, Guttman-Yassky E. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol. 2014; 134: 769-79.
3. Ebner S, Nguyen VA, Forstner M, et al. Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells. J Allergy Clin Immunol. 2007; 119: 982-90.
4. Elentner A, Finke D, Schmuth M, et al. Langerhans cells are critical in the development of atopic dermatitis-like inflammation and symptoms in mice. J Cell Mol Med. 2009; 13: 2658-72.
5. Eyerich K, Pennino D, Scarponi C, et al. IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response. J Allergy Clin Immunol. 2009; 123: 59-66 e4.
6. Lin W, Truong N, Grossman WJ, et al. Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. J Allergy Clin Immunol. 2005; 116: 1106-15.
7. d'Hennezel E, Bin Dhuban K, Torgerson T, et al. The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J Med Genet. 2012; 49: 291-302.
8. Hinz D, Bauer M, Roder S, et al. Cord blood Tregs with stable FOXP3 expression are influenced by prenatal environment and associated with atopic dermatitis at the age of one year. Allergy. 2012; 67: 380-9.
9. Tulic MK, Andrews D, Crook ML, et al. Changes in thymic regulatory T-cell maturation from birth to puberty: differences in atopic children. J Allergy Clin Immunol. 2012; 129: 199-206 e1-4.
10. Szegedi A, Barath S, Nagy G, et al. Regulatory T cells in atopic dermatitis: epidermal dendritic cell clusters may contribute to their local expansion. Br J Dermatol. 2009; 160: 984-93.
11. Brandt C, Pavlovic V, Radbruch A, et al. Low-dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis. Allergy. 2009; 64: 1588-96.
12. + T cells exert Th2-like function after staphylococcal superantigen stimulation in atopic dermatitis patients. Clin Exp Allergy. 2011; 41: 516-25.
13. Ou LS, Goleva E, Hall C, et al. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol. 2004; 113: 756-63.
14. + "regulatory" T-cell subtypes in atopic dermatitis reveals a novel T(H)2-like population. J Allergy Clin Immunol. 2008; 121: 415-22 e3.
15. + T cells associated with disease activity in atopic dermatitis. Ann Allergy Asthma Immunol. 2009; 103: 160-5.
16. Hijnen D, Haeck I, van Kraats AA, et al. Cyclosporin A reduces CD4(+)CD25(+) regulatory T-cell numbers in patients with atopic dermatitis. J Allergy Clin Immunol. 2009; 124: 856-8.
17. Schnopp C, Rad R, Weidinger A, et al. Fox-P3-positive regulatory T cells are present in the skin of generalized atopic eczema patients and are not particularly affected by medium-dose UVA1 therapy. Photodermatol Photoimmunol Photomed. 2007; 23: 81-5.
18. Verhagen J, Akdis M, Traidl-Hoffmann C, et al. Absence of T-regulatory cell expression and function in atopic dermatitis skin. J Allergy Clin Immunol. 2006; 117: 176-83.
19. + regulatory T cells and tacrolimus on inhibition of T-cell proliferation in patients with atopic dermatitis. Br J Dermatol. 2005; 153: 750-7.
20. Agrawal R, Wisniewski JA, Woodfolk JA. The role of regulatory T cells in atopic dermatitis. Curr Probl Dermatol. 2011; 41: 112-24.
21. Bennett CL, van Rijn E, Jung S, et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol. 2005; 169: 569-76.
22. Li M, Hener P, Zhang Z, et al. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci USA. 2006; 103: 11736-41.
23. Li M, Messaddeq N, Teletin M, et al. Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin. Proc Natl Acad Sci USA. 2005; 102: 14795-800.
24. Chappaz S, Flueck L, Farr AG, et al. Increased TSLP availability restores T- and B-cell compartments in adult IL-7 deficient mice. Blood. 2007; 110: 3862-70.
25. Yoo J, Omori M, Gyarmati D, et al. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med. 2005; 202: 541-9.
26. Nakajima S, Igyarto BZ, Honda T, et al. Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling. J Allergy Clin Immunol. 2012; 129: 1048-55 e6.
27. Soumelis V, Reche PA, Kanzler H, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol. 2002; 3: 673-80.
28. + CD25highCD127low regulatory T cell profile and induces a migratory signature specific for homing to sites of inflammation. J Immunol. 2011; 186: 132-42.
29. + T cell responses. J Immunol. 2012; 188: 2146-55.
30. + T regulatory cells. J Immunol. 2010; 184: 3433-41.
31. Dhamne C, Chung Y, Alousi AM, et al. Peripheral and thymic foxp3(+) regulatory T cells in search of origin, distinction, and function. Front Immunol. 2013; 4: 253.
32. Sawant DV, Vignali DA. Once a Treg, always a Treg? Immunol Rev. 2014; 259: 173-91.
33. Simpson TR, Quezada SA, Allison JP. Regulation of CD4 T cell activation and effector function by inducible costimulator (ICOS). Curr Opin Immunol. 2010; 22: 326-32.
34. + regulatory T cells conveying respiratory tolerance. J Immunol. 2012; 189: 1975-82.
35. Bour-Jordan H, Bluestone JA. Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells. Immunol Rev. 2009; 229: 41-66.
36. + T cells in vivo. J Immunol. 2013; 190: 5057-64.
37. + T reg cells. J Exp Med. 2012; 209: 1723-42, S1.
38. Dhainaut M, Coquerelle C, Uzureau S, et al. Thymus-derived regulatory T cells restrain pro-inflammatory Th1 responses by downregulating CD70 on dendritic cells. EMBO J. 2015; 34: 1336-48.
39. Wohlfert EA, Grainger JR, Bouladoux N, et al. GATA3 controls Foxp3(+) regulatory T cell fate during inflammation in mice. J Clin Invest. 2011; 121: 4503-15.
40. Schlitzer A, McGovern N, Ginhoux F. Dendritic cells and monocyte-derived cells: two complementary and integrated functional systems. Semin Cell Dev Biol. 2015; 41: 9-22.
41. Kissenpfennig A, Henri S, Dubois B, et al. Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity. 2005; 22: 643-54.
42. Loser K, Mehling A, Loeser S, et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med. 2006; 12: 1372-9.
43. Yoshida K, Kubo A, Fujita H, et al. Distinct behavior of human Langerhans cells and inflammatory dendritic epidermal cells at tight junctions in patients with atopic dermatitis. J Allergy Clin Immunol. 2014; 134: 856-64.
44. Yoshiki R, Kabashima K, Sugita K, et al. IL-10-producing Langerhans cells and regulatory T cells are responsible for depressed contact hypersensitivity in grafted skin. J Invest Dermatol. 2009; 129: 705-13.
45. Igyarto BZ, Jenison MC, Dudda JC, et al. Langerhans cells suppress contact hypersensitivity responses via cognate CD4 interaction and langerhans cell-derived IL-10. J Immunol. 2009; 183: 5085-93.